Search

Your search keyword '"MacConell, Leigh A."' showing total 219 results

Search Constraints

Start Over You searched for: Author "MacConell, Leigh A." Remove constraint Author: "MacConell, Leigh A."
219 results on '"MacConell, Leigh A."'

Search Results

1. A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis

8. Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH

23. P213 Obeticholic acid improves hepatic fibroinflammation assessed by multiparametric MRI: interim results of the regenerate trial

28. Obeticholic acid improves experimental non-invasive markers of non-alcoholic steatohepatitis and advanced fibrosis: a secondary analysis of the phase 3 regenerate study

30. Obeticholic acid improves hepatic fibroinflammation as assessed by multiparametric magnetic resonance imaging: interim results of the regenerate trial

31. Durability of biochemical improvements through six years of open label treatment with obeticholic acid in patients with primary biliary cholangitis who did not achieve the poise criteria

32. Tu1665 OBETICHOLIC ACID IMPROVES HEPATIC FIBROINFLAMMATION AS ASSESSED BY MULTIPARAMETRIC MRI: INTERIM RESULTS OF THE REGENERATE TRIAL

33. 687 DURABILITY OF BIOCHEMICAL IMPROVEMENTS THROUGH 6 YEARS OF OPEN-LABEL TREATMENT WITH OBETICHOLIC ACID IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS WHO DID NOT ACHIEVE THE POISE CRITERIA

34. Mo1448 OBETICHOLIC ACID IMPROVES TRANSAMINASES IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: RESULTS FROM THE 18-MONTH INTERIM ANALYSIS OF THE REGENERATE STUDY

35. 334 OBETICHOLIC ACID IMPROVES EXPERIMENTAL NON-INVASIVE MARKERS OF NON-ALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS; RESULTS OF A SECONDARY ANALYSIS FROM THE MONTH-18 INTERIM ANALYSIS OF THE REGENERATE STUDY

42. Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitis

48. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

49. 938 Positive Results From REGENERATE: A Phase 3 International, Randomized, Placebo-Controlled Study Evaluating Obeticholic Acid Treatment for NASH

50. CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients

Catalog

Books, media, physical & digital resources